Patient-Reported AutoImmunity Secondary to Cancer immunothErapy

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

905

Participants

Timeline

Start Date

November 29, 2019

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions
Opportunistic Autoimmune Diseases
Interventions
BIOLOGICAL

Biological collection

"Blood samples will be collected only once at enrollment, before initiation of a checkpoint inhibitor.~It will include:~* DNA samples collection~* RNA samples collection~* Blood sample collection"

Trial Locations (1)

67000

Hopitaux universitaires de strasbourg, Strasbourg

All Listed Sponsors
lead

University Hospital, Strasbourg, France

OTHER